EIF4A1 and hepatocellular carcinoma: To conclude, exosomal SENP3-EIF4A1 is a novel beneficial biomarker for clinical detection of HCC, and can spread from normal cells to HCC cells through exosomes, thereby in vivo and in vitro inhibiting HCC progression (108).